Correction of previously published press release regarding Scandion Oncology’s rights issue (trading in BTAs)
The press release of 16 November 2020 (released at 08:31:34) stated incorrectly that the trading in BTAs in Scandion Oncology’s rights issue starts on 3 December 2020. The correct date for the start of trading in BTAs is 26 November 2020 and the trading will be ongoing until the Danish Business Authority has registered the rights issue and BTAs are converted to shares. Below is the correct preliminary timetable for the rights issue.Preliminary timetable for the rights issue Last day of trading in shares including 2020-11-20right to receive subscription rights:First day of trading in